rs4951307
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_018208.4(ETNK2):c.868+670C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0892 in 152,206 control chromosomes in the GnomAD database, including 676 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.089 ( 676 hom., cov: 32)
Consequence
ETNK2
NM_018208.4 intron
NM_018208.4 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.397
Publications
3 publications found
Genes affected
ETNK2 (HGNC:25575): (ethanolamine kinase 2) The protein encoded by this gene is a member of choline/ethanolamine kinase family which catalyzes the first step of phosphatidylethanolamine (PtdEtn) biosynthesis via the cytidine diphosphate (CDP) ethanolamine pathway. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2014]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.105 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| ETNK2 | NM_018208.4 | c.868+670C>T | intron_variant | Intron 5 of 7 | ENST00000367202.9 | NP_060678.2 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0892 AC: 13573AN: 152088Hom.: 675 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
13573
AN:
152088
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.0892 AC: 13574AN: 152206Hom.: 676 Cov.: 32 AF XY: 0.0890 AC XY: 6621AN XY: 74406 show subpopulations
GnomAD4 genome
AF:
AC:
13574
AN:
152206
Hom.:
Cov.:
32
AF XY:
AC XY:
6621
AN XY:
74406
show subpopulations
African (AFR)
AF:
AC:
2064
AN:
41536
American (AMR)
AF:
AC:
1551
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
AC:
465
AN:
3472
East Asian (EAS)
AF:
AC:
352
AN:
5174
South Asian (SAS)
AF:
AC:
347
AN:
4820
European-Finnish (FIN)
AF:
AC:
1226
AN:
10586
Middle Eastern (MID)
AF:
AC:
39
AN:
294
European-Non Finnish (NFE)
AF:
AC:
7289
AN:
68000
Other (OTH)
AF:
AC:
207
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
638
1277
1915
2554
3192
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
164
328
492
656
820
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
242
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.